Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (111-120 of 359) with videos related to

Pageof 36
Sort By:
Urology|September 7, 2012
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomyJens Hansen, Lars Budäus, Jan Spethmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2006
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomyFelix K H Chun, Alberto Briganti, Markus Graefen, et al.
The Journal of Sexual Medicine|January 16, 2009
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomyGeorg Salomon, Hendrik Isbarn, Lars Budaeus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2012
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrenceKatharina Grupp, Sebastian Kohl, Hüseyin Sirma, et al.
BJU International|March 14, 2008
A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancerOlaf J C Hellwinkel, Jan-Peer Rogmann, Legrehndem E Asong, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2013
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancerPhilippe O Gannon, Laurent Lessard, Louis-Mathieu Stevens, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
Pageof 36

Showing results (111-120 of 359) with videos related to

Sort By:
Pageof 36
Urology|September 7, 2012
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomyJens Hansen, Lars Budäus, Jan Spethmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2006
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomyFelix K H Chun, Alberto Briganti, Markus Graefen, et al.
The Journal of Sexual Medicine|January 16, 2009
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomyGeorg Salomon, Hendrik Isbarn, Lars Budaeus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2012
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrenceKatharina Grupp, Sebastian Kohl, Hüseyin Sirma, et al.
BJU International|March 14, 2008
A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancerOlaf J C Hellwinkel, Jan-Peer Rogmann, Legrehndem E Asong, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2013
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancerPhilippe O Gannon, Laurent Lessard, Louis-Mathieu Stevens, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
Pageof 36